Cost-effectiveness analysis of regorafenib for metastatic colorectal cancer.
Year: 2015
Type: conference-abstract
Source: Journal of Clinical Oncology
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: closed
OpenAlex ID: W4249003418
